Gland Pharma, 543245, GLAND Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

47,530.55
42.11
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

44,414.81
0.69%
4.47

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.90
7.88
4.32

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.28
1.53
4.10

PAT CAGR (%)

10 Years
5 Years
3 Years

12.13
-3.25
9.97

P:E (Median)

8 Years
5 Years
3 Years

-
38.38
39.94

P:BV (Average)

8 Years
5 Years
3 Years

-
4.17
3.35

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
20.30
18.46

Earnings Forecasts:

(Updated: 12-09-2026)

Description 2026 2027 2028 2029
Adj EPS 65 13 26.31 56.55
P/E Ratio 44.55 222.73 110.05 51.20
Revenue 32.98 27.11 22.69 6355.4
EBITDA 7342.07 8320.55 9481.76 1538.11
Net Income 1909.92 2246.56 2666.51 932.49
ROA 1194.74 1454.54 1702.76 8.51
P/B Ratio -0.82 -0.64 -0.50 4.85
ROE 3.56 3.21 0.7 9.88
FCFF 11.19 12.2 13.63 533.23
FCFF Yield 469.77 913.21 1006.93 1.43
Net Debt 1.26 2.45 2.7 -2585.17
BVPS -3528.34 -4533.64 -5799.77 596.4

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 1,286.64 1,038.84 23.85% 1,261.59 1,030.35 22.44% 1,177.51 1,010.78 16.50% 1,074.15 1,062.99 1.05%
Expenses 813.13 679.99 19.58% 753.88 636.23 18.49% 755.89 619.64 21.99% 699.26 699.19 0.01%
EBITDA 473.51 358.85 31.95% 507.72 394.12 28.82% 421.63 391.14 7.80% 374.89 363.80 3.05%
EBIDTM 36.80% 34.54% 40.24% 38.25% 35.81% 38.70% 34.90% 34.22%
Other Income 58.82 54.74 7.45% 106.36 43.72 143.28% 60.21 65.06 -7.45% 82.59 57.80 42.89%
Interest 0.69 7.43 -90.71% 6.17 3.45 78.84% 0.50 18.31 -97.27% 3.97 0.17 2,235.29%
Depreciation 43.95 43.77 0.41% 43.11 43.07 0.09% 44.53 43.77 1.74% 44.84 41.61 7.76%
PBT 487.69 362.38 34.58% 564.80 391.32 44.33% 412.46 394.13 4.65% 408.67 379.82 7.60%
Tax 123.30 93.13 32.40% 144.35 101.32 42.47% 104.61 99.01 5.66% 106.68 98.11 8.74%
PAT 364.39 269.26 35.33% 420.45 290.00 44.98% 307.85 295.12 4.31% 302.00 281.71 7.20%
PATM 28.32% 25.92% 33.33% 28.15% 26.14% 29.20% 28.11% 26.50%
EPS 22.08 16.32 35.29% 25.48 17.58 44.94% 18.66 17.89 4.30% 18.30 17.07 7.21%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 1,800.27 1,505.62 19.57% 1,742.79 1,424.91 22.31% 1,695.36 1,384.05 22.49% 1,486.88 1,405.83 5.77%
Expenses 1,310.90 1,137.86 15.21% 1,229.77 1,077.39 14.14% 1,260.49 1,024.10 23.08% 1,172.99 1,108.78 5.79%
EBITDA 489.37 367.76 33.07% 513.02 347.52 47.62% 434.88 359.96 20.81% 313.89 297.06 5.67%
EBIDTM 27.18% 24.43% 29.44% 24.39% 25.65% 26.01% 21.11% 21.13%
Other Income 61.23 57.53 6.43% 111.47 44.03 153.17% 63.17 58.49 8.00% 84.16 59.66 41.07%
Interest 4.36 11.50 -62.09% 10.03 7.45 34.63% 3.93 22.82 -82.78% 7.82 6.11 27.99%
Depreciation 111.26 101.05 10.10% 108.66 95.76 13.47% 107.65 96.33 11.75% 106.31 93.83 13.30%
PBT 434.98 312.74 39.09% 505.80 288.33 75.42% 362.13 299.30 20.99% 283.92 256.78 10.57%
Tax 118.02 97.26 21.34% 139.12 101.79 36.67% 100.65 94.61 6.38% 100.23 93.25 7.49%
PAT 316.96 215.48 47.09% 366.68 186.54 96.57% 261.48 204.69 27.74% 183.68 163.53 12.32%
PATM 17.61% 14.31% 21.04% 13.09% 15.42% 14.79% 12.35% 11.63%
EPS 19.21 13.08 46.87% 22.26 11.32 96.64% 15.87 12.42 27.78% 11.15 9.93 12.29%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 4,799.89 4,552.09 4,116.15 4,167.43 3,616.53 4,400.71 3,462.88 2,633.24 2,044.20 1,619.94 1,479.18 Net Sales Growth 15.86% 10.59% -1.23% 15.23% -17.82% 27.08% 31.51% 28.82% 26.19% 9.52% Cost Of Goods Sold 1,875.91 1,795.15 1,730.60 1,820.31 1,685.42 2,109.22 1,219.00 836.07 626.35 479.75 375.07 Gross Profit 2,923.98 2,756.93 2,385.55 2,347.12 1,931.10 2,291.49 2,243.88 1,797.18 1,417.85 1,140.18 1,104.11 GP Margin 60.92% 60.56% 57.96% 56.32% 53.40% 52.07% 64.80% 68.25% 69.36% 70.38% 74.64% Total Expenditure 3,022.16 2,889.02 2,673.53 2,758.65 2,597.98 2,890.07 2,160.61 1,677.77 1,337.89 1,084.84 854.19 Power & Fuel Cost - 122.38 120.38 117.19 124.84 95.05 74.58 78.50 74.03 60.35 49.24 % Of Sales - 2.69% 2.92% 2.81% 3.45% 2.16% 2.15% 2.98% 3.62% 3.73% 3.33% Employee Cost - 528.82 439.02 409.94 399.70 338.57 311.36 277.66 222.95 179.08 153.42 % Of Sales - 11.62% 10.67% 9.84% 11.05% 7.69% 8.99% 10.54% 10.91% 11.05% 10.37% Manufacturing Exp. - 265.37 222.18 218.95 194.21 179.85 436.84 391.88 337.81 269.23 217.13 % Of Sales - 5.83% 5.40% 5.25% 5.37% 4.09% 12.61% 14.88% 16.53% 16.62% 14.68% General & Admin Exp. - 116.68 98.95 109.27 119.02 93.79 58.62 57.77 47.00 78.76 42.74 % Of Sales - 2.56% 2.40% 2.62% 3.29% 2.13% 1.69% 2.19% 2.30% 4.86% 2.89% Selling & Distn. Exp. - 24.43 23.31 34.66 30.26 40.98 36.69 17.08 13.88 9.93 11.40 % Of Sales - 0.54% 0.57% 0.83% 0.84% 0.93% 1.06% 0.65% 0.68% 0.61% 0.77% Miscellaneous Exp. - 36.19 39.10 48.31 44.53 32.61 23.51 18.82 15.86 7.73 11.40 % Of Sales - 0.80% 0.95% 1.16% 1.23% 0.74% 0.68% 0.71% 0.78% 0.48% 0.35% EBITDA 1,777.75 1,663.07 1,442.62 1,408.78 1,018.55 1,510.64 1,302.27 955.47 706.31 535.10 624.99 EBITDA Margin 37.04% 36.53% 35.05% 33.80% 28.16% 34.33% 37.61% 36.28% 34.55% 33.03% 42.25% Other Income 307.98 303.90 215.07 166.67 240.46 223.94 134.78 139.17 85.56 48.79 33.56 Interest 11.33 18.07 22.84 7.84 7.41 5.24 3.41 7.18 3.56 4.13 6.39 Depreciation 176.43 176.24 169.27 162.11 146.74 110.30 98.78 94.59 81.96 78.21 74.15 PBT 1,873.62 1,772.66 1,465.59 1,405.50 1,104.86 1,619.04 1,334.85 992.87 706.36 501.56 578.01 Tax 478.94 448.76 375.83 362.17 272.58 406.89 337.85 220.01 234.45 180.45 164.28 Tax Rate 25.56% 25.67% 25.64% 25.77% 26.00% 25.13% 25.31% 22.16% 34.16% 35.98% 28.42% PAT 1,394.69 1,299.55 1,089.75 1,043.33 775.83 1,212.15 997.00 772.86 451.91 321.11 413.73 PAT before Minority Interest 1,394.69 1,299.55 1,089.75 1,043.33 775.83 1,212.15 997.00 772.86 451.91 321.11 413.73 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 29.06% 28.55% 26.47% 25.04% 21.45% 27.54% 28.79% 29.35% 22.11% 19.82% 27.97% PAT Growth 22.76% 19.25% 4.45% 34.48% -36.00% 21.58% 29.00% 71.02% 40.73% -22.39% EPS 84.53 78.76 66.05 63.23 47.02 73.46 60.42 46.84 27.39 19.46 25.07

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Net Sales 6,725.30 6,430.65 5,616.50 5,664.72 3,624.60 4,400.71 3,462.88 2,633.24 Net Sales Growth 17.57% 14.50% -0.85% 56.29% -17.64% 27.08% 31.51% Cost Of Goods Sold 2,346.13 2,242.93 2,090.38 2,173.09 1,685.42 2,109.22 1,219.00 836.07 Gross Profit 4,379.17 4,187.72 3,526.12 3,491.63 1,939.17 2,291.49 2,243.88 1,797.18 GP Margin 65.11% 65.12% 62.78% 61.64% 53.50% 52.07% 64.80% 68.25% Total Expenditure 4,974.15 4,801.11 4,347.58 4,331.65 2,599.84 2,890.56 2,160.65 1,677.77 Power & Fuel Cost - 202.85 199.15 229.99 124.84 95.05 74.58 78.50 % Of Sales - 3.15% 3.55% 4.06% 3.44% 2.16% 2.15% 2.98% Employee Cost - 1,628.84 1,401.56 1,256.89 403.26 338.57 311.36 277.66 % Of Sales - 25.33% 24.95% 22.19% 11.13% 7.69% 8.99% 10.54% Manufacturing Exp. - 407.61 347.18 327.19 194.23 179.85 436.84 391.88 % Of Sales - 6.34% 6.18% 5.78% 5.36% 4.09% 12.61% 14.88% General & Admin Exp. - 211.87 206.62 217.36 120.53 94.28 58.66 57.77 % Of Sales - 3.29% 3.68% 3.84% 3.33% 2.14% 1.69% 2.19% Selling & Distn. Exp. - 29.75 27.48 37.46 27.03 40.98 36.69 17.08 % Of Sales - 0.46% 0.49% 0.66% 0.75% 0.93% 1.06% 0.65% Miscellaneous Exp. - 77.25 75.20 89.66 44.53 32.61 23.51 18.82 % Of Sales - 1.20% 1.34% 1.58% 1.23% 0.74% 0.68% 0.71% EBITDA 1,751.16 1,629.54 1,268.92 1,333.07 1,024.76 1,510.15 1,302.23 955.47 EBITDA Margin 26.04% 25.34% 22.59% 23.53% 28.27% 34.32% 37.61% 36.28% Other Income 320.03 316.33 213.61 170.24 240.46 223.94 134.78 139.17 Interest 26.14 33.28 42.00 26.20 7.45 5.24 3.41 7.18 Depreciation 433.88 423.67 377.87 344.57 146.74 110.30 98.78 94.59 PBT 1,586.83 1,488.93 1,062.66 1,132.54 1,111.04 1,618.55 1,334.81 992.87 Tax 458.02 437.26 364.13 360.08 273.54 406.89 337.85 220.01 Tax Rate 28.86% 29.86% 34.27% 31.79% 25.94% 25.14% 25.31% 22.16% PAT 1,128.80 1,027.32 698.53 772.46 781.04 1,211.66 996.96 772.86 PAT before Minority Interest 1,128.80 1,027.32 698.53 772.46 781.04 1,211.66 996.96 772.86 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 16.78% 15.98% 12.44% 13.64% 21.55% 27.53% 28.79% 29.35% PAT Growth 46.55% 47.07% -9.57% -1.10% -35.54% 21.54% 29.00% EPS 68.41 62.26 42.34 46.82 47.34 73.43 60.42 46.84

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 10,810.03 9,755.10 8,995.29 7,953.30 7,158.23 5,903.28 3,646.24 2,862.11 2,410.42 2,089.81 Share Capital 16.48 16.48 16.47 16.47 16.43 16.36 15.49 15.49 15.49 15.49 Total Reserves 10,748.04 9,738.57 8,977.43 7,935.16 7,128.56 5,861.51 3,614.26 2,846.62 2,394.93 2,074.32 Non-Current Liabilities 164.16 142.75 131.60 89.68 93.97 80.31 80.78 127.79 139.37 130.55 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 1.11 2.55 3.26 3.82 3.93 4.07 4.96 5.49 5.92 Long Term Provisions 46.91 22.84 20.69 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 633.02 523.76 414.20 730.20 581.94 512.46 359.02 532.68 378.55 253.38 Trade Payables 485.37 385.87 281.19 589.42 462.76 396.28 249.09 446.20 292.42 189.29 Other Current Liabilities 84.83 88.03 100.94 109.46 76.42 62.36 81.73 72.60 71.13 61.87 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 62.83 49.87 32.07 31.32 42.75 53.82 28.20 13.88 15.01 2.23 Total Liabilities 11,607.21 10,421.61 9,541.09 8,773.18 7,834.14 6,496.05 4,086.04 3,522.58 2,928.34 2,473.74 Net Block 1,688.43 1,744.99 1,693.73 1,570.55 1,502.19 954.23 968.10 928.74 842.64 871.58 Gross Block 2,914.69 2,798.04 2,579.91 2,294.95 2,081.32 1,430.70 1,347.81 1,219.58 1,054.45 1,005.52 Accumulated Depreciation 1,226.26 1,053.05 886.18 724.41 579.13 476.46 379.71 290.83 211.81 133.94 Non Current Assets 5,185.00 4,654.65 4,969.76 1,884.84 1,989.70 1,372.99 1,239.75 1,165.13 1,077.36 1,065.60 Capital Work in Progress 137.63 42.20 120.00 177.22 190.75 337.81 188.47 123.16 198.88 161.15 Non Current Investment 3,292.55 2,789.57 2,385.74 8.16 8.16 0.55 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 66.39 77.89 114.38 128.92 286.40 77.97 81.52 111.89 33.89 29.42 Other Non Current Assets 0.00 0.00 655.91 0.00 2.21 2.43 1.66 1.33 1.95 3.44 Current Assets 6,422.22 5,766.96 4,571.32 6,888.34 5,844.44 5,123.07 2,846.29 2,357.46 1,850.98 1,408.15 Current Investments 0.00 0.00 0.00 0.00 154.87 0.00 0.00 0.00 0.00 0.00 Inventories 1,265.20 1,254.23 1,260.21 1,945.30 1,185.67 1,275.17 756.28 911.88 512.83 378.72 Sundry Debtors 1,520.69 1,142.90 1,171.40 862.84 1,074.81 670.97 601.78 506.10 475.21 417.87 Cash & Bank 3,177.64 2,432.62 1,598.55 3,767.00 3,085.80 3,005.20 1,325.19 753.35 670.84 533.08 Other Current Assets 458.68 126.36 104.76 90.83 343.30 171.72 163.03 186.13 192.10 78.48 Short Term Loans & Adv. 350.72 810.85 436.41 222.37 246.55 87.60 91.80 131.94 126.45 30.20 Net Current Assets 5,789.19 5,243.20 4,157.13 6,158.14 5,262.50 4,610.61 2,487.27 1,824.78 1,472.43 1,154.77 Total Assets 11,607.22 10,421.61 9,541.08 8,773.18 7,834.14 6,496.06 4,086.04 3,522.59 2,928.34 2,473.75

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 10,357.95 9,150.74 8,723.84 7,958.72 7,157.62 5,903.24 3,646.24 Share Capital 16.48 16.48 16.47 16.47 16.43 16.36 15.49 Total Reserves 10,295.95 9,134.21 8,705.99 7,940.59 7,127.95 5,861.46 3,614.26 Non-Current Liabilities 482.17 457.27 488.60 89.68 93.97 80.31 80.78 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 69.92 77.66 106.54 3.26 3.82 3.93 4.07 Long Term Provisions 195.64 145.99 137.21 0.00 0.00 0.00 0.00 Current Liabilities 1,608.40 1,564.85 1,398.36 729.13 582.02 512.53 359.02 Trade Payables 833.87 820.41 767.75 587.35 462.85 396.35 249.09 Other Current Liabilities 657.53 619.87 520.07 109.48 76.42 62.36 81.73 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 117.00 124.56 110.54 32.30 42.75 53.82 28.20 Total Liabilities 12,448.52 11,172.86 10,610.80 8,777.53 7,833.61 6,496.08 4,086.04 Net Block 4,492.33 4,147.23 3,946.75 1,570.55 1,502.19 954.23 968.10 Gross Block 6,784.55 5,613.37 5,011.68 2,294.95 2,081.32 1,430.70 1,347.81 Accumulated Depreciation 2,292.22 1,466.14 1,064.93 724.41 579.13 476.46 379.71 Non Current Assets 4,921.74 4,389.91 4,965.66 1,876.73 1,981.54 1,372.44 1,239.75 Capital Work in Progress 342.18 150.56 237.88 177.22 190.75 337.81 188.47 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 83.07 87.69 119.43 128.96 286.40 77.97 81.52 Other Non Current Assets 4.16 4.43 661.59 0.00 2.21 2.43 1.66 Current Assets 7,526.78 6,782.94 5,645.15 6,900.81 5,852.08 5,123.64 2,846.29 Current Investments 0.00 0.00 0.00 0.00 154.87 0.00 0.00 Inventories 1,743.89 1,685.22 1,655.24 1,945.30 1,185.67 1,275.17 756.28 Sundry Debtors 1,891.38 1,516.53 1,558.69 871.39 1,074.81 670.97 601.78 Cash & Bank 3,359.11 2,556.21 1,839.43 3,770.68 3,093.44 3,005.75 1,325.19 Other Current Assets 532.41 149.85 102.61 91.00 343.30 171.75 163.03 Short Term Loans & Adv. 404.00 875.13 489.19 222.44 246.55 87.60 91.80 Net Current Assets 5,918.38 5,218.09 4,246.79 6,171.68 5,270.05 4,611.11 2,487.27 Total Assets 12,448.52 11,172.85 10,610.81 8,777.54 7,833.62 6,496.08 4,086.04

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 1,135.23 1,073.67 1,135.97 367.89 791.29 604.93 700.93 185.06 201.93 476.46 PBT 1,748.31 1,465.59 1,405.50 1,048.40 1,619.04 1,334.85 992.87 686.36 501.56 578.01 Adjustment 19.18 -5.15 23.15 37.38 -28.19 17.30 32.15 76.12 50.94 70.69 Changes in Working Capital -212.86 -34.59 23.38 -407.00 -393.05 -435.80 -79.94 -353.94 -193.43 -10.86 Cash after chg. in Working capital 1,554.63 1,425.84 1,452.02 678.78 1,197.80 916.36 945.07 408.53 359.07 637.85 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -419.40 -352.17 -316.05 -310.89 -406.51 -311.43 -244.14 -223.47 -157.14 -161.39 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -95.56 1,578.20 -2,923.92 1,208.22 -1,010.23 -1,524.55 -766.08 -314.14 -358.84 -96.65 Net Fixed Assets -212.08 -140.33 -227.74 -200.10 -503.56 -232.23 -193.54 -89.41 -86.66 55.65 Net Investments -502.98 -403.83 -2,377.58 154.87 -162.48 -0.55 0.00 0.00 0.00 0.17 Others 619.50 2,122.36 -318.60 1,253.45 -344.19 -1,291.77 -572.54 -224.73 -272.18 -152.47 Cash from Financing Activity -316.18 -339.54 -7.40 14.92 34.90 1,238.46 -6.87 -2.93 -3.59 -116.42 Net Cash Inflow / Outflow 723.49 2,312.33 -1,795.35 1,591.04 -184.04 318.84 -72.01 -132.01 -160.50 263.39 Opening Cash & Equivalents 2,432.62 116.20 1,905.22 311.18 491.92 169.50 236.40 372.84 533.08 273.23 Closing Cash & Equivalent 3,177.64 2,432.62 116.20 1,905.22 311.18 491.92 169.50 236.40 372.84 533.08

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 1,031.39 914.73 996.80 363.97 790.77 604.93 700.93 PBT 1,464.58 1,062.66 1,132.54 1,054.58 1,618.55 1,334.81 992.87 Adjustment 276.75 211.94 223.60 38.19 -28.27 17.30 32.15 Changes in Working Capital -254.50 -6.06 -53.20 -417.94 -393.01 -435.76 -79.94 Cash after chg. in Working capital 1,486.84 1,268.53 1,302.95 674.83 1,197.28 916.35 945.07 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -455.45 -353.80 -306.15 -310.87 -406.51 -311.43 -244.14 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 137.73 1,704.74 -1,756.91 1,208.19 -1,002.62 -1,524.00 -766.08 Net Fixed Assets -212.08 -140.33 -227.74 -200.10 -503.56 -232.23 Net Investments -502.98 -403.83 -2,377.58 154.87 -162.48 -0.55 Others 852.79 2,248.90 848.41 1,253.42 -336.58 -1,291.22 Cash from Financing Activity -416.97 -433.48 -799.42 14.92 34.90 1,238.46 -6.87 Net Cash Inflow / Outflow 752.14 2,185.99 -1,559.53 1,587.08 -176.95 319.39 -72.01 Opening Cash & Equivalents 2,556.21 357.09 1,908.89 318.82 492.46 169.50 236.40 Closing Cash & Equivalent 3,359.11 2,556.21 357.09 1,908.89 318.82 492.46 169.50

Financial Ratios

Standalone /

Consolidated

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 653.35 592.08 546.04 482.80 434.87 359.30 234.25 1847.12 1555.61 1348.70 ROA 11.80% 10.92% 11.39% 9.34% 16.92% 18.84% 20.32% 14.01% 11.89% 18.15% ROE 12.67% 11.62% 12.31% 10.28% 18.62% 20.97% 23.81% 17.14% 14.27% 21.97% ROCE 17.18% 15.87% 16.67% 13.97% 24.86% 28.00% 30.68% 26.11% 22.41% 30.04% Fixed Asset Turnover 1.59 1.53 1.71 1.65 2.51 2.49 2.05 1.80 1.58 1.47 Receivable days 106.79 102.61 89.08 97.78 72.40 67.08 76.78 87.61 100.43 94.03 Inventory Days 101.01 111.48 140.38 158.00 102.05 107.06 115.61 127.19 100.26 91.25 Payable days 88.57 70.34 87.28 113.93 74.33 96.62 73.57 99.56 79.68 57.64 Cash Conversion Cycle 119.22 143.75 142.17 141.84 100.12 77.52 118.83 115.24 121.01 127.64 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 97.74 65.18 180.20 142.41 309.98 392.34 139.24 193.80 122.59 91.43

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 625.91 555.40 529.56 483.12 434.84 359.30 234.25 ROA 8.70% 6.41% 7.97% 9.40% 16.91% 18.84% 18.91% ROE 10.56% 7.82% 9.26% 10.34% 18.61% 20.97% 21.29% ROCE 14.96% 11.97% 13.63% 14.04% 24.85% 28.00% 27.39% Fixed Asset Turnover 1.04 1.06 1.55 1.66 2.51 2.49 1.95 Receivable days 96.72 99.92 78.29 97.99 72.40 67.08 83.41 Inventory Days 97.32 108.54 116.00 157.65 102.05 107.06 104.83 Payable days 134.60 138.65 113.80 113.72 74.35 96.63 52.71 Cash Conversion Cycle 59.43 69.81 80.48 141.92 100.10 77.51 135.53 Total Debt/Equity 0.02 0.03 0.04 0.00 0.00 0.00 0.00 Interest Cover 45.01 26.30 44.23 142.61 309.77 392.33 139.24

Top Investors:

hdfc mutual fund - hdfc mid-cap fund

mirae asset large & midcap fund

nippon life india trustee ltd- a/c nippon india growth mid cap fund

sbi large & midcap fund

icici prudential india opportunities fund

dsp small cap fund

government pension fund global

uti-flexi cap fund

llp

Annual Reports:

News Update:

USFDA completes routine GMP inspection at Gland Pharma’s Visakhapatnam facility
2nd Sep 2026, 12:26 PM

The inspection was concluded with ZERO Form 483 Observations
Read More
Gland Pharma reports 47% jump in Q1 consolidated net profit
11th Aug 2026, 12:00 PM

The total consolidated income of the company has increased by 19.09% at Rs 1,861.50 crore for Q1FY27
Read More
Gland Pharma - Quarterly Results
11th Aug 2026, 00:00 AM

Read More
Gland Pharma executes strategic agreement with Global Pharmaceutical Company
10th Aug 2026, 09:08 AM

The agreement is for the technology transfer, manufacturing and supply of a portfolio of sterile injectable products for global markets
Read More
Gland Pharma, Neuland Laboratories join forces for sterile API manufacturing
6th Aug 2026, 10:10 AM

The company will establish a sterile manufacturing suite for APIs pertaining to microparticle depot products
Read More
Gland Pharma gets USFDA’s approval for Sugammadex Injection
29th Jul 2026, 12:44 PM

According to IQVIA, the product had US sales of approximately $1.6 billion for the twelve months ending April 2026
Read More

Gland Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543245 | NSE: GLAND

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Gland Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543245 | NSE: GLAND

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: